Great announcement, the effects of this will take time to be realized IMO.
Monash, Dr Paul all huge stamps of credibility. Not some meme tier university or research institution in a foreign country... *cough cough*
All thats needed now is a major player(s) to take notice of IHL due to this ann and recognize the opportunity in having a sub 200M MC AUD psychedelics company with another 4 company makers in the works.
Could be from overseas... like North America. They have far more $$ to throw around than us Aussies.
Anyways, looking forward to getting future guidance on this upcoming Phase 2 Human Trial. First Mover on the ASX.... The coming days and weeks ignore the machinations of sellers they will regret it very soon.
- Forums
- ASX - By Stock
- Ann: IHL initiates psilocybin clinical trial for anxiety disorder
Great announcement, the effects of this will take time to be...
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online